Artrya (ASX:AYA): SAPPHIRE strong market strategy getting noticed
SAPPHIRE: Connecting Salix with the best in cardiac medicine‍ First announced in February 2025, the three-phase Salix-based Analysis of Plaque to...
163 Views
Artrya (ASX:AYA): Initiation of coverage; $2.35 price target; 5.1x current share price; Salix is a cloud-base
Cloud-base, AI-driven cardiac imaging diagnostics Artrya is the Perth-based developer of Salix, a cloud-based, AI-driven imaging diagnostic tool...
210 Views